Saybrook Capital’s Allergan Inc AGN Stock Holding History

Saybrook Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-48,325	Closed	-$10.3M	–	51
2014 Q4	$10.3M	Sell	48,325 -1,750	-3%	-$348K	5.97%	3
2014 Q3	$8.92M	Hold	50,075	–	–	5.4%	3
2014 Q2	$8.47M	Sell	50,075 -4,635	-8%	-$722K	5.1%	4
2014 Q1	$6.79M	Sell	54,710 -100	-0.2%	-$12.2K	4.3%	4
2013 Q4	$6.09M	Buy	54,810 +5,000	+10%	+$478K	3.85%	8
2013 Q3	$4.5M	Buy	49,810 +12,270	+33%	+$1.1M	3.27%	18
2013 Q2	$3.16M	Buy	+37,540	New	+$3.89M	2.29%	22

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Saybrook Capital's AGN Position: Q1 2015 in Review

Saybrook Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 48,325 shares — an estimated $10.3M sold.

Saybrook Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $10.3M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Saybrook Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Saybrook Capital sold 48,325 Allergan Inc shares in Q1 2015, an estimated $10.3M.
Saybrook Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Saybrook Capital's Allergan Inc position peaked at $10.3M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Saybrook Capital's 13F filing for Q1 2015, filed 11 May 2015.